| NP0351203 | semiantarmycin E | |  | C20H32O6
368.4700 Da 368.21989 Da | | 13C NMR Spectrum (1D, 175.0, CD3OD, simulated) | | 13C NMR Spectrum (1D, 176 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 700 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 176 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 700 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 700 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, CD3OD, experimental) |
|
| NP0351202 | semiantarmycin D | |  | C27H45NO8
511.6560 Da 511.31452 Da | | 13C NMR Spectrum (1D, 175.0, CD3OD, simulated) | | 13C NMR Spectrum (1D, 176 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 700 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 176 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 700 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 700 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 176 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 700 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 176 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 700 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 700 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, CD3OD, experimental) |
|
| NP0351197 | semiantarmycin B | |  | C33H55NO13
673.7970 Da 673.36734 Da | | 13C NMR Spectrum (1D, 175.0, CD3OD, simulated) | | 1H NMR Spectrum (1D, 700 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 176 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 700 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 176 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 700 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 176 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 700 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 176 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 700 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 700 MHz, CD3OD, experimental) |
|
| NP0351196 | (3Z,6E)-14-Methyl-alpha-farnesene | |  | C16H26
218.3840 Da 218.20345 Da | | 1H NMR Spectrum (1D, 500 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 126 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) |
|
| NP0351195 | ruticarponine B | |  | C15H19NO3
261.3210 Da 261.13649 Da | | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) |
|
| NP0351193 | ruticarponine A | |  | C15H19NO4
277.3200 Da 277.13141 Da | | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) |
|
| NP0351192 | Tricycloalternarene Z | |  | C21H26O6
374.4330 Da 374.17294 Da | |
| NP0351191 | Didehydrotricycloalternarene Z | |  | C21H28O6
376.4490 Da 376.18859 Da | | 1H NMR Spectrum (1D, 600.0, C2D6OS, simulated) | | 13C NMR Spectrum (1D, 150.0, C2D6OS, simulated) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) |
|
| NP0351190 | Tricycloalternarene P | |  | C21H28O6
376.4490 Da 376.18859 Da | | 1H NMR Spectrum (1D, 600.0, C2D6OS, simulated) | | 13C NMR Spectrum (1D, 150.0, C2D6OS, simulated) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) |
|
| NP0351186 | pometin B | |  | C48H76O17
925.1190 Da 924.50825 Da | | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 500 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) |
|
| NP0351185 | stigmasterol-3-O-α-glucoside | |  | C35H58O6
574.8430 Da 574.42334 Da | |
| NP0351184 | tychonamide D | |  | C74H109N13O20
1500.7570 Da 1499.79118 Da | |
| NP0351183 | tychonamide E | |  | C72H105N13O20
1472.7030 Da 1471.75988 Da | |
| NP0351182 | 2α,3α- dihydroxy-11-oxooleana-12-en-28-oic acid ( | |  | C30H46O5
486.6930 Da 486.33452 Da | |
| NP0351181 | 2α,3β-dihydroxy-12-oxooleana-9(11)-en-28-13β,28-lactone | |  | C30H44O5
484.6770 Da 484.31887 Da | |
| NP0351180 | 3β-hydroxy-11-oxo-28-norolean-12,17-diene | |  | C29H44O2
424.6690 Da 424.33413 Da | |
| NP0351174 | (7R, 8R, 8′R) 4′-guaiacylglyceryl-evofolin B | |  | C27H30O10
514.5270 Da 514.18390 Da | |
| NP0351173 | sophorol E | |  | C27H32O10
516.5430 Da 516.19955 Da | |
| NP0351172 | (7S, 8S, 8′R) 4′-guaiacylglyceryl-evofolin B | |  | C27H30O10
514.5270 Da 514.18390 Da | | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) |
|
| NP0351171 | guaiacylglycerol 8'-vanillin ether | |  | C18H20O7
348.3510 Da 348.12090 Da | |
| NP0351170 | leptoleplsol D1 | |  | C27H32O10
516.5430 Da 516.19955 Da | |
| NP0351167 | kaempferol-3-O-α-rhamnoside | |  | C21H20O10
432.3775 Da 432.10565 Da | | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 500 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) |
|
| NP0351164 | ficusal | |  | C18H18O6
330.3360 Da 330.11034 Da | |
| NP0351163 | 2, 3-bis-(4-hydroxy-3-methoxyphenyl)-3-methoxy-propanol | |  | C18H22O6
334.3680 Da 334.14164 Da | |
| NP0351162 | erythro-2, 3-bis-(4-hydroxy-3-methoxypheyl)-ethoxypropan-1-ol | |  | C19H24O6
348.3950 Da 348.15729 Da | |